Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Depreciation & Amortization (CF) (2020 - 2025)

Cytek Biosciences' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 2.27% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $7.6 million, up 5.09%, while the annual FY2025 figure was $7.6 million, 5.09% up from the prior year.
  • Depreciation & Amortization (CF) reached $1.9 million in Q4 2025 per CTKB's latest filing, down from $1.9 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.9 million in Q3 2025 to a low of $72000.0 in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $1.2 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): crashed 61.9% in 2022, then surged 2354.17% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $685000.0 in 2021, then increased by 11.09% to $761000.0 in 2022, then skyrocketed by 114.32% to $1.6 million in 2023, then grew by 13.67% to $1.9 million in 2024, then grew by 2.27% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Depreciation & Amortization (CF) are $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).